Craig D Platt, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Severe Combined Immunodeficiency | 4 | 2022 | 223 | 1.650 |
Why?
|
| Lymphopenia | 3 | 2022 | 285 | 1.360 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2021 | 547 | 1.200 |
Why?
|
| Agammaglobulinemia | 4 | 2022 | 167 | 0.870 |
Why?
|
| Lymphadenitis | 1 | 2019 | 98 | 0.650 |
Why?
|
| Homozygote | 3 | 2019 | 1785 | 0.640 |
Why?
|
| Umbilical Cord | 1 | 2019 | 180 | 0.630 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2017 | 16 | 0.620 |
Why?
|
| von Willebrand Disease, Type 3 | 1 | 2016 | 5 | 0.580 |
Why?
|
| Janus Kinase 3 | 1 | 2016 | 78 | 0.570 |
Why?
|
| BCG Vaccine | 1 | 2019 | 369 | 0.560 |
Why?
|
| Anion Transport Proteins | 1 | 2017 | 142 | 0.550 |
Why?
|
| Pneumonia, Bacterial | 1 | 2019 | 316 | 0.550 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 209 | 0.530 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.520 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 571 | 0.510 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2019 | 570 | 0.500 |
Why?
|
| Neutropenia | 1 | 2019 | 895 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 3597 | 0.470 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 581 | 0.460 |
Why?
|
| Desensitization, Immunologic | 2 | 2020 | 483 | 0.430 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 260 | 0.420 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 669 | 0.420 |
Why?
|
| Actins | 1 | 2019 | 2121 | 0.410 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 612 | 0.390 |
Why?
|
| Macrophage Activation Syndrome | 3 | 2022 | 111 | 0.390 |
Why?
|
| Adenosine Deaminase | 2 | 2023 | 241 | 0.350 |
Why?
|
| T-Lymphocytes | 5 | 2022 | 10180 | 0.340 |
Why?
|
| Skin | 2 | 2019 | 4364 | 0.330 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 4665 | 0.320 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 2703 | 0.320 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5442 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2022 | 17446 | 0.310 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1378 | 0.300 |
Why?
|
| Membrane Proteins | 3 | 2019 | 7880 | 0.280 |
Why?
|
| Fatal Outcome | 3 | 2020 | 1850 | 0.270 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2020 | 652 | 0.270 |
Why?
|
| Endocytosis | 1 | 2010 | 985 | 0.260 |
Why?
|
| Consanguinity | 4 | 2022 | 454 | 0.250 |
Why?
|
| Sequence Deletion | 2 | 2020 | 1526 | 0.240 |
Why?
|
| Mevalonate Kinase Deficiency | 1 | 2023 | 19 | 0.230 |
Why?
|
| Receptors, Immunologic | 1 | 2010 | 1423 | 0.230 |
Why?
|
| Sweet Syndrome | 1 | 2023 | 47 | 0.230 |
Why?
|
| Child, Preschool | 16 | 2022 | 41006 | 0.220 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 328 | 0.210 |
Why?
|
| Pedigree | 4 | 2022 | 4644 | 0.200 |
Why?
|
| Vasculitis | 2 | 2023 | 519 | 0.200 |
Why?
|
| Lymphocyte Activation | 4 | 2022 | 5524 | 0.200 |
Why?
|
| Mutation | 12 | 2023 | 29786 | 0.190 |
Why?
|
| Receptors, IgE | 1 | 2022 | 389 | 0.190 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2564 | 0.190 |
Why?
|
| Neonatal Screening | 2 | 2022 | 591 | 0.190 |
Why?
|
| Meningitis, Bacterial | 1 | 2022 | 218 | 0.180 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9648 | 0.180 |
Why?
|
| STAT2 Transcription Factor | 1 | 2019 | 27 | 0.180 |
Why?
|
| Mycobacterium bovis | 1 | 2020 | 150 | 0.170 |
Why?
|
| Mycobacterium Infections | 1 | 2020 | 119 | 0.170 |
Why?
|
| Dendritic Cells | 2 | 2010 | 2725 | 0.170 |
Why?
|
| Ion Transport | 2 | 2018 | 320 | 0.170 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 297 | 0.170 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2020 | 142 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2916 | 0.160 |
Why?
|
| Infant | 10 | 2022 | 35136 | 0.160 |
Why?
|
| Flagella | 1 | 2018 | 103 | 0.160 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3240 | 0.160 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 638 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 327 | 0.160 |
Why?
|
| Mice, Mutant Strains | 2 | 2021 | 1866 | 0.150 |
Why?
|
| Child | 16 | 2022 | 77709 | 0.150 |
Why?
|
| Genomics | 1 | 2013 | 5720 | 0.150 |
Why?
|
| Interleukins | 1 | 2022 | 791 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2020 | 541 | 0.140 |
Why?
|
| Humans | 41 | 2023 | 744343 | 0.140 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1588 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2023 | 1676 | 0.140 |
Why?
|
| Codon, Nonsense | 1 | 2017 | 281 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1880 | 0.130 |
Why?
|
| Necrosis | 1 | 2019 | 1643 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 523 | 0.130 |
Why?
|
| Phenotype | 6 | 2023 | 16365 | 0.130 |
Why?
|
| Infertility, Male | 1 | 2018 | 409 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2021 | 711 | 0.130 |
Why?
|
| Cell Size | 1 | 2017 | 643 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 613 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2017 | 262 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 587 | 0.120 |
Why?
|
| Skin Tests | 1 | 2016 | 613 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2022 | 2035 | 0.120 |
Why?
|
| Apoptosis | 2 | 2021 | 9727 | 0.120 |
Why?
|
| Psoriasis | 1 | 2022 | 898 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 1041 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 820 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1788 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 1861 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1988 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2019 | 19229 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 1179 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3133 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Siblings | 1 | 2016 | 854 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 2015 | 389 | 0.100 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 884 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 2 | 2020 | 4803 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 1219 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 986 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 622 | 0.100 |
Why?
|
| Allergens | 1 | 2018 | 1320 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1580 | 0.090 |
Why?
|
| Female | 17 | 2022 | 380194 | 0.090 |
Why?
|
| Male | 19 | 2021 | 350118 | 0.090 |
Why?
|
| Genetic Counseling | 1 | 2013 | 600 | 0.090 |
Why?
|
| Mice | 8 | 2022 | 81183 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 2988 | 0.080 |
Why?
|
| West Nile Fever | 1 | 2009 | 81 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2460 | 0.080 |
Why?
|
| Genetic Linkage | 1 | 2013 | 2421 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4186 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2023 | 25625 | 0.080 |
Why?
|
| Colitis | 1 | 2015 | 1170 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2019 | 3444 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 2645 | 0.070 |
Why?
|
| Quality Improvement | 2 | 2019 | 3749 | 0.070 |
Why?
|
| Alleles | 1 | 2016 | 6933 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 1475 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14557 | 0.060 |
Why?
|
| Thymidylate Synthase | 1 | 2004 | 75 | 0.060 |
Why?
|
| Animals | 9 | 2022 | 168757 | 0.060 |
Why?
|
| Biopsy | 1 | 2016 | 6756 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4386 | 0.060 |
Why?
|
| Genes, Protozoan | 1 | 2004 | 163 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3022 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13989 | 0.060 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2004 | 143 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2010 | 1539 | 0.060 |
Why?
|
| Genotype | 2 | 2020 | 12951 | 0.060 |
Why?
|
| Toxoplasma | 1 | 2004 | 150 | 0.060 |
Why?
|
| Adolescent | 6 | 2021 | 85781 | 0.060 |
Why?
|
| Pandemics | 2 | 2020 | 8388 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2699 | 0.050 |
Why?
|
| Coatomer Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 686 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5137 | 0.050 |
Why?
|
| Twins, Monozygotic | 1 | 2022 | 458 | 0.050 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2020 | 16 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2022 | 375 | 0.050 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2020 | 30 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 56430 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15540 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 272 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11483 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 410 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5974 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2022 | 894 | 0.040 |
Why?
|
| Anions | 1 | 2018 | 133 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 349 | 0.040 |
Why?
|
| Otitis Media | 1 | 2020 | 277 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
| Eczema | 1 | 2020 | 231 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2009 | 1905 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2018 | 253 | 0.040 |
Why?
|
| Gene Expression | 3 | 2020 | 7799 | 0.040 |
Why?
|
| Vaccination | 1 | 2009 | 3278 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 1463 | 0.040 |
Why?
|
| Adult | 5 | 2023 | 214055 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2023 | 77449 | 0.030 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 546 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2009 | 5021 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 12072 | 0.030 |
Why?
|
| Cytokines | 2 | 2021 | 7322 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 713 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2020 | 1200 | 0.030 |
Why?
|
| Testis | 1 | 2018 | 803 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1144 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2017 | 641 | 0.030 |
Why?
|
| Iran | 1 | 2017 | 708 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2018 | 625 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 163280 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 873 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4204 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 808 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 4776 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 961 | 0.030 |
Why?
|
| China | 1 | 2018 | 2248 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2022 | 1916 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
| Middle Aged | 3 | 2021 | 213383 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2540 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2021 | 2044 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2019 | 4479 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3200 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3778 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 23403 | 0.020 |
Why?
|
| West Nile Virus Vaccines | 1 | 2009 | 4 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2915 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 2959 | 0.020 |
Why?
|
| Seizures | 1 | 2022 | 2859 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 2133 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2727 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 2958 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2009 | 407 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3610 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2009 | 635 | 0.020 |
Why?
|
| RNA, Protozoan | 1 | 2004 | 43 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2009 | 1402 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7181 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2009 | 1133 | 0.010 |
Why?
|
| Hospitalization | 1 | 2023 | 10262 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 1000 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12959 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2004 | 249 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9856 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2216 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10638 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
| Asthma | 1 | 2019 | 6011 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21746 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 4740 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12797 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57776 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 5867 | 0.010 |
Why?
|
| United States | 1 | 2019 | 69872 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18111 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 21827 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7722 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 13033 | 0.010 |
Why?
|